Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Oncoimmunology|September 14, 2016
Large-scale microarray profiling reveals four stages of immune escape in non-Hodgkin lymphomasMarie Tosolini, Christelle Algans, Frédéric Pont, et al.
Antimicrobial Agents and Chemotherapy|March 16, 2011
Activity of carbapenems combined with clavulanate against murine tuberculosisNicolas Veziris, Chantal Truffot, Jean-Luc Mainardi, et al.
The Journal of Antimicrobial Chemotherapy|March 25, 2016
Rifabutin: where do we stand in 2016?Yoann Crabol, Emilie Catherinot, Nicolas Veziris, et al.
Plos One|March 17, 2011
Sterilizing activity of second-line regimens containing TMC207 in a murine model of tuberculosisNicolas Veziris, Murad Ibrahim, Nacer Lounis, et al.
Plos Neglected Tropical Diseases|October 19, 2016
Sterilizing Activity of Fully Oral Intermittent Regimens against Mycobacterium Ulcerans Infection in MiceAurélie Chauffour, Jérôme Robert, Nicolas Veziris, et al.
Plos Neglected Tropical Diseases|May 8, 2025
Unprecedented in vivo activity of telacebec against Mycobacterium lepraeAurélie Chauffour, Emmanuelle Cambau, Kevin Pethe, et al.
La Revue Du Praticien|March 29, 2024
[Advances in antibiotic therapy for tuberculosis]Thomas Maitre, Lorenzo Guglielmetti, Jérôme Robert, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2003
Fluoroquinolone-containing third-line regimen against Mycobacterium tuberculosis in vivoNicolas Veziris, Chantal Truffot-Pernot, Alexandra Aubry, et al.
Pageof 10